Gal Markel
- Immunology top 0.5%
- Oncology top 1%
- Molecular Biology top 5%
- Epidemiology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Ofer MandelboimJacob SchachterMichal J. BesserGil KatzTal I. ArnonOrit ItzhakiRonnie Shapira‐FrommerRoi Gazit
- Topics
- CAR-T cell therapy research (34 papers)Immunotherapy and Immune Responses (32 papers)Immune Cell Function and Interaction (31 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Gal Markel
125 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 112
- Immunology 3.0k
- Oncology 2.5k
- Molecular Biology 1.5k
- Epidemiology 509
- Radiology, Nuclear Medicine and Imaging 503
Countries citing papers authored by Gal Markel
This map shows the geographic impact of Gal Markel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Markel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Markel more than expected).
Fields of papers citing papers by Gal Markel
This network shows the impact of papers produced by Gal Markel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Markel. The network helps show where Gal Markel may publish in the future.
Co-authorship network of co-authors of Gal Markel
This figure shows the co-authorship network connecting the top 25 collaborators of Gal Markel. A scholar is included among the top collaborators of Gal Markel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gal Markel. Gal Markel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 8 | |
| 4 | 14 | |
| 5 | 21 | |
| 6 | 37 | |
| 7 | 6 | |
| 8 | 46 | |
| 9 | 12 | |
| 10 | 294 | |
| 11 | 70 | |
| 12 | 59 | |
| 13 | 12 | |
| 14 | 352 | |
| 15 | Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma. | 33 |
| 16 | 49 | |
| 17 | 81 | |
| 18 | 118 | |
| 19 | 63 | |
| 20 | 90 |
About Gal Markel
Gal Markel is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 126 papers that have together received 5.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (34 papers), Immunotherapy and Immune Responses (32 papers) and Immune Cell Function and Interaction (31 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (2.5k citations) and Immunology and Allergy (211 citations). Gal Markel has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Ofer Mandelboim, Jacob Schachter, Michal J. Besser, Gil Katz, Tal I. Arnon, Orit Itzhaki, Ronnie Shapira‐Frommer, Roi Gazit, Jacob H. Hanna and Avraham J. Treves. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.